Dischidia bengalensis
Dischidia bengalensis · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Dischidia bengalensis is a plant species currently being investigated for its significant therapeutic potential in pharmacological research. Studies focusing on its dichloromethane, ethyl acetate, methanolic, and n-hexane extracts have revealed a rich profile of bioactive compounds, including fatty acids and terpenoids. These chemical constituents contribute to the plant's demonstrated analgesic and thrombolytic activities. Such properties suggest that the plant may offer medicinal benefits for managing conditions such as acute pain, rheumatoid arthritis, and thrombosis. Consequently, this species serves as a promising subject for developing new treatments for inflammatory and circulatory disorders.
- Synonyms
- Dischidia Loeseneriana · Dischidia Bengalensis Var. Cuneifolia · 4 more
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Dischidia bengalensis is a versatile plant known by various regional names across the globe. In certain areas, it is referred to by the common name bengalinpussiköynnös or urnovka bengálska. Cultivators in Thailand recognize this species as เดฟเบงกอล, while Japanese enthusiasts call it ベンガルアケビカズラ. Additionally, it is identified in Chinese botanical contexts as 孟加拉眼树莲. These diverse linguistic labels highlight the widespread interest and recognition this unique plant enjoys internationally.
Sources: Catalogue of Life (COL)
Synonyms
Dischidia bengalensis is a complex species that has been classified under several different names throughout botanical history. Taxonomic studies have identified multiple varieties, including Dischidia bengalensis var. cuneifolia and Dischidia bengalensis var. spathulata. Furthermore, the plant has previously been documented under the synonymous names Dischidia cuneifolia and Dischidia loeseneriana. Researchers also recognize Dischidia pseudobenghalensis as a formal synonym within its scientific lineage. Understanding these various nomenclatural relationships is essential for accurate identification in the field.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Dischidia bengalensis belongs to the vast kingdom Plantae, representing a unique branch of the botanical world. Within this kingdom, it is classified under the class Equisetopsida and the order Gentianales. It further resides in the family Apocynaceae, a group known for its diverse floral characteristics. The plant is also a distinct member of the genus Dischidia. Through these various biological hierarchies, its specific place in nature is clearly defined.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Dischidia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Dischidia bengalensis is a fascinating plant with a broad distribution stretching across various regions of Asia. It is native to the tropical landscapes of the Indian Subcontinent, where it can be found in Assam, Bangladesh, and the East Himalaya. The species also thrives within the unique ecosystems of Nepal, showcasing its adaptability to different terrains. Beyond the subcontinent, its presence extends into Indo-China, specifically within the forests of Myanmar. This wide geographic range highlights the ecological significance of the species throughout the tropical Asian landscape.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Dischidia bengalensis is a specialized herb characterized by its unique growth form. This plant relies on an obligatory climbing habit to navigate its environment and reach optimal light.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Dischidia bengalensis has emerged as a significant medicinal plant with multi-target pharmacological potential. Recent investigations into its methanolic extract and solvent fractions have confirmed its potent analgesic properties. Specifically, the n-hexane fraction demonstrated a pronounced ability to alleviate pain in both writhing and tail-immersion models. Beyond pain management, the plant also exhibits significant thrombolytic activity through the lysis of human blood clots. These findings suggest that the species could serve as a vital source of lead compounds for treating cardiovascular and pain-related disorders.
Compounds
Dischidia bengalensis has emerged as a significant subject of pharmacological interest due to its diverse chemical profile. Recent phytochemical screening and GC-MS profiling have revealed that this medicinal plant contains a variety of bioactive constituents. Specifically, the research highlights that Dischidia bengalensis contains fatty acids and terpenoids, which are essential to its therapeutic potential. These identified compounds are believed to contribute to the plant's impressive anti-inflammatory, analgesic, and thrombolytic activities. Consequently, the presence of these substances positions the plant as a promising source for developing new treatments for cardiovascular and inflammatory disorders.
Conditions
Dischidia bengalensis demonstrates significant pharmacological potential by treating acute pain through its analgesic properties. The plant's methanolic extract effectively treats carrageenan-induced paw edema by providing substantial anti-inflammatory inhibition. Research also indicates that its extracts can treat human blood clot lysis, offering a possible application for cardiovascular health. Furthermore, the medicinal plant shows promise in treating rheumatoid arthritis by addressing key inflammatory targets. Finally, the bioactive constituents of Dischidia bengalensis assist in treating thrombosis, making it a valuable source for novel therapeutics.
Preparations
Dischidia bengalensis was prepared as a methanolic extract to investigate its anti-inflammatory, analgesic, and thrombolytic properties. To further analyze its pharmacological potential, the plant was also prepared as a dichloromethane fraction. Additionally, the species was processed as an ethyl acetate fraction for integrated in vitro and in vivo evaluation. The study also involved preparing Dischidia bengalensis as an n-hexane fraction, which demonstrated a pronounced analgesic response. These various solvent-based preparations allowed for a comprehensive assessment of the plant's bioactive constituents.